SII logo
SII logo
products

PRODUCTS SUPPLIED IN INDIA

Serum - Protection from birth onwards

QUADROVAX PFS, QUADROVAX SD (liquid)

Diphtheria, Tetanus, Pertussis (Whole Cell) and Haemophilus Type b Conjugate Vaccine (Adsorbed) I.P.

Quadrovax

INDICATION

For the active immunization of infants of the age of 6 weeks and above against Diphtheria, Tetanus, Pertussis and
Haemophilus Influenzae type b

ROUTE OF ADMINISTRATION

Intramuscular Injection.

IMMUNIZATION SCHEDULE

  • First 3 doses should be given 4 weeks apart at 6, 10 and 14 weeks.
  • A booster dose of DTwP and Haemophilus influenzae type b Conjugate Vaccine can be given at the age of 15-18 months.

COMPOSITION

  • Each single 0.5 ml dose contains
  • Diphtheria Toxoid ≥20 Lf to ≤ 30 Lf
  • Tetanus Toxoid ≥5 Lf to ≤ 25 Lf
  • B. Pertussis ≥ 4 IU
  • Purified capsular polysaccharide (PRP) 10 mcg
  • Tetanus Toxoid (carrier protein) 19 to 33 mcg
  • Adsorbed on Aluminium Phosphate, Al+++ ≤ 1.25 mg
  • Preservative: 0.01% Thiomersal
PRESENTATION:
Quadrovax SD: 1 dose vial of 0.5 ml
Quadrovax PFS: 1 x 0.5 ml - 1 dose pre-filled syringe